Autophagic Degradation of NBR1 Restricts Metastatic Outgrowth during Mammary Tumor Progression

Area of Science:

• Oncology
• Cell Biology
• Cancer Research

Background:

• Autophagy is a therapeutic target in oncology, but its role in cancer metastasis is unclear.
• Metastasis is the primary cause of cancer mortality, underscoring the need to understand its regulation.

Purpose of the Study:

• To investigate the role of autophagy in mammary cancer progression and metastasis.
• To identify mechanisms by which autophagy influences metastatic outgrowth and cell differentiation.

Main Methods:

• Utilized mammary cancer models with temporal deletion of autophagy regulators.
• Performed transcriptomic analysis to identify molecular changes associated with autophagy deficiency.
• Conducted pharmacological and genetic induction of autophagy.
• Analyzed human breast cancer data for correlation with autophagy gene expression.

Main Results:

• Genetic ablation of autophagy reduced primary tumor growth but increased spontaneous metastasis.
• Autophagy deficiency induced a pro-metastatic basal differentiation phenotype in tumor cells, linked to NBR1 accumulation.
• Induction of autophagy suppressed pro-metastatic differentiation and metastatic outgrowth.
• Autophagy gene expression inversely correlated with pro-metastatic signatures in human breast cancer data.

Conclusions:

• Autophagy plays a dual role in cancer, inhibiting metastasis despite potentially affecting primary tumor growth.
• Autophagy-dependent control of NBR1 is crucial for preventing metastatic progression.
• Targeting autophagy may offer a therapeutic strategy to suppress cancer metastasis.